The pages in this Chapter show the Galien Award winning Products for 2014 Sovaldi/Hemacord/TrevoProVue
The Chapter for each year includes an introduction followed by:
- YouTube coverage of the Award Winning Products for the specific year
- Index list of the winning Products followed by the product details for each Winner
- Tweets or Tributes left for each product.
Were you part of the Award Winning Team, or perhaps you were a patient?
2.Register and Add your message and share this extra-ordinary and difficult journey which has allowed the discovery of this therapeutic innovation.
Please begin your message by stating the name of the Product and whether you are a Researcher or a Patient.Research Team Members 2013 Next
2014 - Best Pharmaceutical Agents: Sovaldi® - Gilead Sciences
Sofosbuvir (trade name Sovaldi®) is a hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor indicated for the treatment of chronic hepatitis C infection (CHC) as a component of a combination antiviral treatment regimen. SOVALDI efficacy has been established in subjects with HCV genotype 1, 2, 3 or 4 infection, including those with hepatocellular carcinoma meeting Milan criteria (awaiting liver transplantation) and those with HCV/HIV-1 co-infection.Laureate 2014 Previous